Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

NCT04787991 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma

Interventions

DRUG: Nivolumab (Cohort A)
DRUG: Ipilimumab (Cohort A, B and C)
DRUG: Hydroxychloroquine (HCQ) (Cohort B)
DRUG: Nab-paclitaxel (nP) (Cohort A, B and C)
DRUG: Gemcitabine (gem) (Cohort A, B and C)
DRUG: NG350A (Cohort C)

Sponsor

Cancer Insight, LLC

Collaborators

[object Object]
[object Object]
[object Object]